Tenax Therapeutics Inc expected to post a loss of $8.14 a share - Earnings Preview

Tenax Therapeutics

26/03/2024 20:41

* Tenax Therapeutics Inc  TENX.OQ   TENX.O  is expected
to show no
change in quarterly revenue when it reports  results on March 28
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Tenax Therapeutics Inc
is for
a loss of $8.14 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Tenax
Therapeutics Inc is $32.50​, above​ its last closing price
of $3.70. ​​​

This summary was machine generated March 26 at 20:41 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)